Pfizer | Financial Buzz

Biotechnology Healthcare Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

CDC Study Finds One Dose of Pfizer or Moderna Vaccines were 80% Effective

Rebecca Urena03/29/202103/29/2021

2449

According to a study by Centers for Disease Control and Prevention, Pfizer (NYSE: PFE) and Moderna’s (NASDAQ: MRNA) vaccines were 90% effective after two doses, and 80% effective after...

Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Pfizer Begins Human Trial Testing Oral Drug Against Covid-19

Rebecca Urena03/23/202103/23/2021

1936

Pfizer (NYSE: PFE) announced Tuesday that it has commenced the clinical trial for an experimental oral antiviral Covid-19 drug. The pill is expected to be used at the first...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

2139

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson’s Covid Vaccine Receives Approval in the EU

Rebecca Urena03/11/2021

2963

Johnson & Johnson’s (NYSE: JNJ) one-dose coronavirus vaccine has been approved by the European Union, the fourth licensed vaccine to be authorized for the E.U’s 27 nations. On Thursday,...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Pfizer BioNTech COVID-19 Vaccine Confirmed to Lower Incidence Rates in Individuals

Bryan Shin03/11/2021

3878

Pfizer Inc. (NYSE: PFE), The Israel Ministry of Health and BioNTech SE (NASDAQ: BNTX) reported evidence that demonstrates lower incidence rates of COVID-19 disease in individuals that are vaccinated...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson Files for Emergency Use Authorization

Rebecca Urena02/05/2021

3322

Johnson and Johnson (NYSE: JNJ) has requested emergency use authorization from the Food and Drug Administration for its single-dose COVID19 vaccine. The company recently shared data demonstrating its vaccine...

Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Vaxart Falls 60% Despite Announcing Positive Clinical Trial Data

Rebecca Urena02/03/2021

3637

Vaxart (NASDAQ: VXRT), an American biotechnology company, announced that its preliminary oral COVID-19 vaccine had demonstrated positive results in early-stage clinical trials featuring 35 healthy adults. Nevertheless, the company’s...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

J&J Single-Dose Covid Vaccine 66% Effective

Rebecca Urena01/29/202101/29/2021

3048

Johnson & Johnson (NYSE: JNJ) announced Friday that its single-dose coronavirus vaccine was currently 66% effective against Covid-19. Nevertheless, the vaccine seems to be less efficient when it comes...

Investing News Life Style Market News Medical Use Pharmaceutical Technology The Market Buzz Your Environment

Oxford-AstraZeneca Covid-19 Vaccine Approved in the U.K

Rebecca Urena12/30/202012/30/2020

3348

The United Kingdom approved AstraZeneca’s (OTCMKTS: AZNCF) – the Oxford University’s coronavirus vaccine on Wednesday, becoming the first country to do so. The vaccine is said to be a...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Myovant Sciences Stock Rises After Pfizer Collaboration

Danny Abramov12/28/2020

3826

Myovant Sciences Ltd. (NYSE: MYOV) stock jumped more than 26% after the clinical-stage biopharmaceutical company announced a collaboration with Pfizer Inc. (NYSE: PFE) to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH)...

Tag: Pfizer